[EN] ARYLAMINOMETHYL PROPENYL BENZHYDROXYAMID DERIVATIVES WITH INHIBITORY ACTIVITY AGAINST HISTONE DEACETYLASE AND METHOD FOR THE PREPARATION THEREOF [FR] DERIVES D'ARYLAMINOMETHYL-PROPENYL-BENZHYDROXYAMIDE PRESENTANT UNE ACTIVITE INHIBITRICE CONTRE L'HISTONE DEACETYLASE, ET METHODE DE PREPARATION DESDITS DERIVES
[EN] ARYLAMINOMETHYL PROPENYL BENZHYDROXYAMID DERIVATIVES WITH INHIBITORY ACTIVITY AGAINST HISTONE DEACETYLASE AND METHOD FOR THE PREPARATION THEREOF [FR] DERIVES D'ARYLAMINOMETHYL-PROPENYL-BENZHYDROXYAMIDE PRESENTANT UNE ACTIVITE INHIBITRICE CONTRE L'HISTONE DEACETYLASE, ET METHODE DE PREPARATION DESDITS DERIVES
NAPHTHALENYLOXYPROPENYL DERIVATIVES HAVING INHIBITORY ACTIVITY AGAINST HISTONE DEACETYLASE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
申请人:Lee Cheol Hae
公开号:US20100069630A1
公开(公告)日:2010-03-18
The present invention discloses novel naphthalenyloxypropenyl derivatives useful for inhibiting the enzyme activity of histone deacetylase, leading effective suppression of cancer cell proliferation.
本发明公开了一种新型萘氧基丙烯酰衍生物,用于抑制组蛋白去乙酰化酶的酶活性,从而有效抑制癌细胞增殖。
Naphthalenyloxypropenyl derivatives having inhibitory activity against histone deacetylase and pharmaceutical composition comprising the same
申请人:Korea Research Institute of Chemical Technology
公开号:US08053435B2
公开(公告)日:2011-11-08
The present invention discloses novel naphthalenyloxypropenyl derivatives useful for inhibiting the enzyme activity of histone deacetylase, leading effective suppression of cancer cell proliferation.
本发明揭示了新型萘氧丙烯酰基衍生物,可用于抑制组蛋白去乙酰化酶的酶活性,从而有效抑制癌细胞增殖。
WO2008/54154
申请人:——
公开号:——
公开(公告)日:——
A Facile One-Pot Conversion of Acetates of the Baylis−Hillman Adducts to [<i>E</i>]-α-Methylcinnamic Acids
作者:Deevi Basavaiah、Marimganti Krishnamacharyulu、Rachakonda Suguna Hyma、Pakala K. S. Sarma、Nagaswamy Kumaragurubaran
DOI:10.1021/jo981761b
日期:1999.2.1
A simple and convenient stereoselective synthesis of [E]-alpha-methylcinnamic acids via the nucleophilic addition of hydride ion from sodium borohydride to methyl 3-acetoxy-3-aryl-2-methylenepropanoates followed by hydrolysis and crystallization is described. Efficacy of this methodology in the synthesis of [E]-p-(myristyloxy)-alpha-methylcinnamic acid, an active hypolipidemic agent, and [E]-p-(carbomethoxy)-alpha-methylcinnamic acid, a valuable synthon for an orally active serine protease inhibitor, is also demonstrated.